📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Inflammatory bowel disease has no borders: engaging patients as partners to deliver global, equitable and holistic health care (2024)

First Author: Lamb C

Attributed to: IBD-RESPONSE: Defining microbial predictors of responsiveness to biological therapies in Crohn's disease and ulcerative colitis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(24)00983-8

PubMed Identifier: 38768627

Publication URI: http://europepmc.org/abstract/MED/38768627

Type: Journal Article/Review

Parent Publication: The Lancet

Issue: 10451

ISSN: 0140-6736